Literature DB >> 21914720

The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Jason R Cannon1, J Timothy Greenamyre.   

Abstract

Neurodegeneration describes the loss of neuronal structure and function. Numerous neurodegenerative diseases are associated with neurodegeneration. Many are rare and stem from purely genetic causes. However, the prevalence of major neurodegenerative diseases is increasing with improvements in treating major diseases such as cancers and cardiovascular diseases, resulting in an aging population. The neurological consequences of neurodegeneration in patients can have devastating effects on mental and physical functioning. The causes of most cases of prevalent neurodegenerative diseases are unknown. The role of neurotoxicant exposures in neurodegenerative disease has long been suspected, with much effort devoted to identifying causative agents. However, causative factors for a significant number of cases have yet to be identified. In this review, the role of environmental neurotoxicant exposures on neurodegeneration in selected major neurodegenerative diseases is discussed. Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis were chosen because of available data on environmental influences. The special sensitivity the nervous system exhibits to toxicant exposure and unifying mechanisms of neurodegeneration are explored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914720      PMCID: PMC3216414          DOI: 10.1093/toxsci/kfr239

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  304 in total

Review 1.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease.

Authors:  John Savory; Mary M Herman; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2006-11       Impact factor: 4.472

Review 3.  The neurobiology of amyotrophic lateral sclerosis.

Authors:  André Bento-Abreu; Philip Van Damme; Ludo Van Den Bosch; Wim Robberecht
Journal:  Eur J Neurosci       Date:  2010-06-07       Impact factor: 3.386

4.  Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.

Authors:  H H Liou; M C Tsai; C J Chen; J S Jeng; Y C Chang; S Y Chen; R C Chen
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

Review 5.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Authors:  Rashid Deane; Berislav V Zlokovic
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

Review 6.  Lipid peroxidation and neurodegenerative disease.

Authors:  Tanea T Reed
Journal:  Free Radic Biol Med       Date:  2011-06-30       Impact factor: 7.376

Review 7.  Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Authors:  Mala V Rao; Ralph A Nixon
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

8.  Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain.

Authors:  L F Rodella; F Ricci; E Borsani; A Stacchiotti; E Foglio; G Favero; R Rezzani; C Mariani; R Bianchi
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

9.  Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.

Authors:  Sakae Yumoto; Shigeo Kakimi; Akihiro Ohsaki; Akira Ishikawa
Journal:  J Inorg Biochem       Date:  2009-08-15       Impact factor: 4.155

10.  Determination of trichloroethylene in biological samples by headspace solid-phase microextraction gas chromatography/mass spectrometry.

Authors:  Yongzhen Liu; Srinivasa Muralidhara; James V Bruckner; Michael G Bartlett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-24       Impact factor: 3.205

View more
  100 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

3.  Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.

Authors:  Biswadeep Das; Sriya Priyadarshini Dash; Swabhiman Mohanty; Paritosh Patel
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

5.  Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.

Authors:  Angela Cruz-Hernandez; Zeynep Sena Agim; Paola C Montenegro; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Neurotoxicology       Date:  2018-03       Impact factor: 4.294

Review 6.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

Review 7.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

Review 8.  Biomarkers of metabolic disorders and neurobehavioral diseases in a PCB- exposed population: What we learned and the implications for future research.

Authors:  Jyothirmai J Simhadri; Christopher A Loffredo; Tomas Trnovec; Lubica Palkovicova Murinova; Gail Nunlee-Bland; Janna G Koppe; Greet Schoeters; Siddhartha Sankar Jana; Somiranjan Ghosh
Journal:  Environ Res       Date:  2020-09-13       Impact factor: 6.498

9.  Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

Authors:  Marianne van der Mark; Roel Vermeulen; Peter C G Nijssen; Wim M Mulleners; Antonetta M G Sas; Teus van Laar; Hans Kromhout; Anke Huss
Journal:  Int Arch Occup Environ Health       Date:  2014-06-18       Impact factor: 3.015

10.  Editor's Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice.

Authors:  Eileen M Martinez; Alison L Young; Yash R Patankar; Brent L Berwin; Li Wang; Katharine M von Herrmann; Jaclyn M Weier; Matthew C Havrda
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.